Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Dexamethasone Versus Metoclopramide for Prophylaxis of Nausea and Vomiting After Cataract Surgery

Efficacy of Dexamethasone Versus Metoclopramide for Prophylaxis of Nausea and Vomiting After Cataract Surgery: A Double-blind Randomized Controlled Study

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Postoperative nausea and vomiting (PONV) is a common consequence of ambulatory surgery, affecting up to 80% of high-risk patients and 20-30% overall. Despite being widespread, a prior survey found that patients are more averse to PONV than pain and other significant postoperative problems. Furthermore, even mild cases of PONV can have serious repercussions, such as postanesthesia care unit (PACU) workflow disruption, delayed discharges, higher medical costs, and lower patient satisfaction.PONV following intraocular surgery can be unpleasant and may lead to serious complications including suprachoroidal hemorrhage (SCH). SCH is a potentially serious condition that occurs when the posterior ciliary arteries or vortex veins burst, resulting in blood in the suprachoroidal region. The hypothesis is that dexamethasone will lower the incidence of PONV after cataract surgery when compared with metoclopramide.

Who May Be Eligible (Plain English)

Who May Qualify: - Age: 40-80 years, both sexes. - ASA physical status class I to III. Who Should NOT Join This Trial: - history of motion sickness - patients with gastrointestinal disorders or gastro-oesophageal reflux - patients taking medications with known antiemetic activity - previous postoperative vomiting - allergy to bupivacaine - allergy to metoclopramide or dexamethasone Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age: 40-80 years, both sexes. * ASA physical status class I to III. Exclusion Criteria: * history of motion sickness * patients with gastrointestinal disorders or gastro-oesophageal reflux * patients taking medications with known antiemetic activity * previous postoperative vomiting * allergy to bupivacaine * allergy to metoclopramide or dexamethasone

Treatments Being Tested

OTHER

0.9% normal saline

patients in group P will receive 0.9% normal saline

DRUG

Metoclopramide 10mg

patients in group M will receive 10 mg metoclopramide

DRUG

Dexamethasone

patients in group D will receive 8 mg dexamethasone

Locations (1)

Alexandria University
Alexandria, Egypt